/biz/ - Business & Finance

All your gains are belong to me now.

All your gains belong to me now.

Want to capitalize on the Wuhan novel coronavirus? It demonstrates 80% genetic similarity to the SARS virus in 2002.

There have been a few companies that have developed antivirals that have decreased mortality and adverse events from the earlier coronaviruses; endpoints of less ICU admissions, acute respiratory distress syndrome, hypoxic events.

GILD manufactures remdesivir, it demonstrates some efficacy in treating MERS-CoV and SARS-coV. In addition, ABT labs manufactures lopinavir and ritonavir which showed clinical benefit in SARS-coV patients. NVAX is also developing a noval nanoparticle vaccine against this virus.

Expect fundings from charitable organizations such as the Bill and Melinda Gates Foundation, or government investment in said companies if this new virus becomes a pandemic.